Covance to Acquire Merck's Gene Expression Lab

The deal to sell the lab to Covance comes less than two months after Merck announced it would sell Rosetta Biosoftware to Microsoft.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.